PGR and triple-negative breast carcinoma: Due to the absence of ER, PR, and Her2/Neu overexpression, no targeted therapy exists for patients with triple negative breast cancer, and thus these patients must endure chemotherapeutic therapies with unpleasant toxic side-effects [40].